{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:28:50Z","timestamp":1786994930367,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2017YFA0104903"],"award-info":[{"award-number":["2017YFA0104903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LR17H090001"],"award-info":[{"award-number":["LR17H090001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671040"],"award-info":[{"award-number":["31671040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31701036"],"award-info":[{"award-number":["31701036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neuroscience.2018.01.042","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T02:34:51Z","timestamp":1517884491000},"page":"264-270","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Introducing Autoimmunity at the Synapse by a Novel Animal Model of Experimental Autoimmune Myasthenia Gravis"],"prefix":"10.1016","volume":"374","author":[{"given":"Jianwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2018.01.042_b0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archneur.58.6.869","article-title":"Titin, thymoma, and myasthenia gravis","volume":"58","author":"Aarli","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-017-1754-2","article-title":"Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration","author":"Attia","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1749-6632.1998.tb10978.x","article-title":"Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma","volume":"841","author":"Baggi","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0020","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.2174\/1381612821666150316123233","article-title":"Mouse models of myasthenia gravis","volume":"21","author":"Ban","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0025","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1523\/JNEUROSCI.1733-14.2014","article-title":"LRP4 is critical for neuromuscular junction maintenance","volume":"34","author":"Barik","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0030","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0035","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00415-017-8514-z","article-title":"Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis","volume":"264","author":"Cordts","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2016.2032","article-title":"Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin","volume":"73","author":"Cortes-Vicente","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2012.06833.x","article-title":"The search for new antigenic targets in myasthenia gravis","volume":"1275","author":"Cossins","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0055","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.autrev.2014.08.039","article-title":"Cortactin autoantibodies in myasthenia gravis","volume":"13","author":"Gallardo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0060","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis \u2013 autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0085","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ene.13300","article-title":"Multiple antibody detection in 'seronegative' myasthenia gravis patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.10095","article-title":"\u201cCrisis\u201d in myasthenia gravis: an historical perspective","volume":"26","author":"Keesey","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2016.04.003","article-title":"MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK","volume":"295\u2013296","author":"Kucukerden","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0110","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1981.tb33725.x","article-title":"Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity","volume":"377","author":"Lennon","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/mus.25591","article-title":"Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis","author":"Li","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0125","doi-asserted-by":"crossref","first-page":"e0135378","DOI":"10.1371\/journal.pone.0135378","article-title":"Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis","volume":"10","author":"Marino","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.expneurol.2015.02.010","article-title":"Thymoma related myasthenia gravis in humans and potential animal models","volume":"270","author":"Marx","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0135","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1523\/JNEUROSCI.03-03-00644.1983","article-title":"Fine structural distribution of acetylcholine receptors at developing mouse neuromuscular junctions","volume":"3","author":"Matthews-Bellinger","year":"1983","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0140","doi-asserted-by":"crossref","first-page":"880","DOI":"10.15252\/emmm.201607298","article-title":"DOK7 gene therapy enhances motor activity and life span in ALS model mice","volume":"9","author":"Miyoshi","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/clin.1994.1039","article-title":"Evaluation of myosin-reactive antibodies from a panel of myasthenia gravis patients","volume":"70","author":"Mohan","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2014.00252","article-title":"ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease","volume":"8","author":"Moloney","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0155","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.12.005","article-title":"Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis","volume":"244","author":"Mori","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0170","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","article-title":"LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner","volume":"23","author":"Ohkawara","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0175","first-page":"1","article-title":"Decreased bone mineral density in experimental myasthenia gravis in C57BL\/6 mice","author":"Oshima","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.celrep.2012.08.004","article-title":"Increasing MuSK activity delays denervation and improves motor function in ALS mice","volume":"2","author":"Perez-Garcia","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0195","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8206.1","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms","volume":"5","author":"Phillips","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.25438","article-title":"Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients","volume":"55","author":"Rivner","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archneur.62.3.442","article-title":"Striational antibodies in myasthenia gravis: reactivity and possible clinical significance","volume":"62","author":"Romi","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/35097557","article-title":"Induction, assembly, maturation and maintenance of a postsynaptic apparatus","volume":"2","author":"Sanes","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0215","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaneurol.2015.0853","article-title":"Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia","volume":"72","author":"Selcen","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-2427(00)00255-5","article-title":"Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis","volume":"78","author":"Shelton","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0225","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2015.05.012","article-title":"LRP4 in neuromuscular junction and bone development and diseases","volume":"80","author":"Shen","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0235","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0240","doi-asserted-by":"crossref","first-page":"16556","DOI":"10.1073\/pnas.1408409111","article-title":"The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses","volume":"111","author":"Tezuka","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0245","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/acn3.26","article-title":"LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients","volume":"1","author":"Tzartos","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","article-title":"Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Tzartos","year":"1987","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0260","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/08820139.2017.1299754","article-title":"Immunization with recombinantly expressed lrp4 induces experimental autoimmune myasthenia gravis in C57BL\/6 mice","volume":"46","author":"Ulusoy","year":"2017","journal-title":"Immunol Invest"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice","volume":"151","author":"Ulusoy","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0270","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0275","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation","volume":"75","author":"Wu","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0280","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/dev.038711","article-title":"To build a synapse: signaling pathways in neuromuscular junction assembly","volume":"137","author":"Wu","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0285","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1167\/iovs.07-0271","article-title":"A new mouse model of autoimmune ocular myasthenia gravis","volume":"48","author":"Yang","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0295","doi-asserted-by":"crossref","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0300","first-page":"445","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0305","doi-asserted-by":"crossref","first-page":"40624","DOI":"10.1074\/jbc.M111.279307","article-title":"Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK)","volume":"286","author":"Zhang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0310","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1101\/gad.180885.111","article-title":"Structural basis of agrin-LRP4-MuSK signaling","volume":"26","author":"Zong","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.neuroscience.2018.01.042_b0320","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mus.23645","article-title":"Double-seropositive myasthenia gravis","volume":"47","author":"Zouvelou","year":"2013","journal-title":"Muscle Nerve"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218300721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218300721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T10:38:30Z","timestamp":1569062310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452218300721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":64,"alternative-id":["S0306452218300721"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.01.042","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732629755.793552103","asserted-by":"object"}]},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}